Sciencast Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-37,752
| Closed | -$3.97M | – | 356 |
|
|
2025
Q4 | $3.97M | Buy |
+37,752
| New | +$3.54M | 0.55% | 83 |
|
|
2025
Q1 | – | Sell |
-31,583
| Closed | -$3.14M | – | 313 |
|
|
2024
Q4 | $3.14M | Buy |
31,583
+27,449
| +664% | +$2.83M | 0.86% | 1 |
|
|
2024
Q3 | $469K | Buy |
4,134
+834
| +25% | +$99.1K | 0.14% | 185 |
|
|
2024
Q2 | $409K | Buy |
3,300
+871
| +36% | +$112K | 0.14% | 182 |
|
|
2024
Q1 | $321K | Sell |
2,429
-4,187
| -63% | -$516K | 0.2% | 149 |
|
|
2023
Q4 | $721K | Sell |
6,616
-11,665
| -64% | -$1.21M | 0.39% | 106 |
|
|
2023
Q3 | $1.88M | Buy |
+18,281
| New | +$1.97M | 0.85% | 10 |
|
|
2022
Q2 | $1.28M | Buy |
+14,400
| New | +$1.28M | 0.29% | 124 |
|
|
2022
Q1 | – | Sell |
-39,323
| Closed | -$3.02M | – | 675 |
|
|
2021
Q4 | $3.02M | Buy |
+39,323
| New | +$3.13M | 0.53% | 58 |
|
|
2021
Q1 | – | Sell |
-57,247
| Closed | -$4.51M | – | 611 |
|
|
2020
Q4 | $4.51M | Buy |
57,247
+26,152
| +84% | +$2M | 0.94% | 9 |
|
|
2020
Q3 | $2.38M | Sell |
31,095
-20,925
| -40% | -$1.64M | 0.91% | 14 |
|
|
2020
Q2 | $3.86M | Buy |
52,020
+42,776
| +463% | +$3.22M | 0.97% | 8 |
|
|
2020
Q1 | $679K | Buy |
+9,244
| New | +$727K | 0.19% | 70 |
|
|
2019
Q4 | – | Sell |
-13,624
| Closed | -$1.11M | – | 552 |
|
|
2019
Q3 | $1.11M | Sell |
13,624
-6,498
| -32% | -$521K | 0.37% | 89 |
|
|
2019
Q2 | $1.56M | Sell |
20,122
-6,846
| -25% | -$524K | 0.88% | 22 |
|
|
2019
Q1 | $2.08M | Buy |
+26,968
| New | +$2.02M | 0.74% | 31 |
|
|
2018
Q2 | – | Sell |
-10,740
| Closed | -$607K | – | 348 |
|
|
2018
Q1 | $607K | Buy |
+10,740
| New | +$580K | 0.3% | 123 |
|
|
2017
Q4 | – | Sell |
-23,364
| Closed | -$1.25M | – | 388 |
|
|
2017
Q3 | $1.25M | Buy |
23,364
+14,202
| +155% | +$861K | 0.7% | 34 |
|
|
2017
Q2 | $560K | Buy |
+9,162
| New | +$558K | 0.31% | 120 |
|
|
2017
Q1 | – | Sell |
-13,525
| Closed | -$760K | – | 394 |
|
|
2016
Q4 | $760K | Buy |
+13,525
| New | +$792K | 1.04% | 13 |
|
|
2016
Q3 | – | Sell |
-20,541
| Closed | -$1.13M | – | 202 |
|
|
2016
Q2 | $1.13M | Sell |
20,541
-728
| -3% | -$38.7K | 0.5% | 63 |
|
|
2016
Q1 | $1.07M | Buy |
+21,269
| New | +$1.04M | 0.85% | 37 |
|
Other funds holding MRK
VCM
VPM
Sciencast Management's MRK Position: Q1 2026 in Review
Sciencast Management sold out of Merck (MRK) in Q1 2026, closing a stake of 37,752 shares — an estimated $3.97M sold.
Sciencast Management first reported a position in MRK in Q1 2016 and held it in 22 quarters. The position peaked at $4.51M in Q4 2020. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Sciencast Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
- Sciencast Management sold 37,752 Merck shares in Q1 2026, an estimated $3.97M.
- Sciencast Management first reported a position in Merck in Q1 2016 and held it in 22 quarters.
- Sciencast Management's Merck position peaked at $4.51M in Q4 2020.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Sciencast Management's 13F filing for Q1 2026, filed 14 May 2026.